medigraphic.com
ISSN 1527-3172 (Digital)

2022, Número 2

<< Anterior Siguiente >>

MEDICC Review 2022; 24 (2)


Evaluation of SARS-CoV-2 Rapid Antigen Tests in Use on the Isle of Youth, Cuba

González-Fiallo S, Mena-Rodríguez I, Castro-Batista P, Doeste-Hernández VM, Louit-Laborit V

Idioma: Ingles.
Referencias bibliográficas: 31
Paginas: 15-19
Archivo PDF: 158.71 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Cañete Villafranca R, Noda Albelo AL, FerreiraMoreno V, Brito Pérez K, García Herrera AL.SARS-Cov-2, el virus emergente que causala pandemia de COVID-19. Rev Med ElectrónMatanzas [Internet]. 2020 May–Jun [cited 2021May 17];42(3):1862–81. Available at: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1684-18242020000301862&lng=es. Spanish.

  2. Folgueira López ME. Utilización del test de detecciónde antígeno de SARS-CoV-2 en exudadonasofaríngeo para el control de la infecció+n porCOVID-19. Rev Esp Quimioter [Internet]. 2020Dec [cited 2021 Apr 25];33(6):390–1. Availableat: https://seq.es/abstract/rev-esp-quimioter-2020-november-24. https://doi.org/10.37201/req/127.2020. Spanish.

  3. Bachelet VC. ¿Conocemos las propiedades diagnósticasde las pruebas usadas en COV- ID-19?Una revisión rápida de la literatura reci- entementepublicada. Medwave. 2020 Apr 28;20(3):e7890.https://doi.org/10.5867/medwave.2020.03.7891.Spanish, English.

  4. Mojica Crespo R, Morales Crespo MM. PandemiaCOVID-19, la nueva emergencia sanitariade preocupación internacional: una revisión.Semergen. 2020 Aug;46 Suppl 1:65–77. Availableat: https://www.sciencedirect.com/science/article/pii/S1138359320301714. https://doi.org/10.1016/j.semerg.2020.05.010. Spanish.

  5. Sheridan C. Fast, portable tests comeonline to curb coronavirus pandemic. Nat Biotechnol.2020 May;38(5):515–8. https://doi.org/10.1038/d41587-020-00010-2.

  6. Aleaga Santiesteban Y, Sanabria Negrín JG.Evaluación de los test rápidos en el HospitalGeneral de Bata, Guinea Ecuatorial. Rev CienciasMédicas [Internet]. 2015 Nov–Dec [cited2021 Apr 25];19(6):1201–9. Available at: https://www.researchgate.net/publication/317514943_Evaluacion_de_los_test_rapidos_en_el_Hos pital_General_de_Bata_Guinea_Ecuatorial. Spanish.

  7. Bravo Grau S, Cruz JP. Estudios de exactituddiagnóstica: herramientas para su interpretación.Rev Chil Radiol [Internet]. 2015 [cited 2021 Apr20];21(4):158–64. Available at: https://scielo.conicyt.cl/pdf/rchradiol/v21n4/art07.pdf. Spanish.

  8. Redacción Médica [Internet]. Madrid: RedacciónMédica; c2004-2022. SANIDAD HOY. Coronavirus:OMS apela al “test, test, test” para evitarmuertes en niños; 2020 Mar 16 [cited 2021Jan 15]; [about 2 p.]. Available at: https://www.redaccionmedica.com/secciones/sanidad-hoy/coronavirus-oms-apela-al-test-test-test-para-evitar-muertes-en-ninos-5431. Spanish.

  9. World Health Organization. Implementaciónde la prueba rápida de detección deantíge- nos para COVID-19 – Estudio piloto.Geneva: World Health Organization; 2020 Oct27 [cited 2021 April 25]. 4 p. Available at: https://docs.bvsalud.org/biblioref/2020/10/1127580/ops-implementacion-prd-ag.pdf. Spanish.

  10. Bulilete O, Lorente P, Leiva A, Carandell E,Oli- ver A, Rojo E, et al. Evaluation of the Panbio™ rapid antigen test for SARS-CoV-2 inprimary health care centers and test sites.medRx- iv [Preprint]. 2020 Nov 16. https://doi.org/10.1101/2020.11.13.20231316

  11. Iglὁi Z, Velzing J, van Beek J, van de Vijver D,Aron G, Ensing R, et al. Clinical evaluation ofthe Roche/SD Biosensor rapid antigen testwith symptomatic, nonhospitalized patients ina municipal health service drive-through testingsite. medRxiv [Preprint]. 2020 Nov 20. https://doi.10.3201/eid2705.204688

  12. Pollock NR, Jacobs JR, Tran K, CranstonAE, Smith S, O’Kane CY, et al. Performanceand implementation evaluation of the AbbottBinaxNOW rapid antigen test in a high-throughputdrive-through community testing site in Massachusetts.J Clin Microbiol. 2021 Apr 20. https://doi.org/10.1128/jcm.00083-21

  13. Pilarowski G, Márquez C, Rubio L, Peng J, MartínezJ, Black D, et al. Field performance andpublic health response using the BinaxNOWTM rapid Severe Acute Respiratory SyndromeCoronavirus 2 (SARSCoV-2) antigen detectionassay during community-based testing. ClinInfect Dis [Internet]. 2021 Nov 1 [cited 2021 Nov29];73(9):e3098–101. Available at: https://academic.oup.com/cid/article/73/9/e3098/6052342

  14. Shah M, Salvatore PP, Ford L, Kamitani E,Whal- ey MJ, Mitchell K, et al. Performanceof repeat BinaxNOW Severe Acute RespiratorySyndrome Coronavirus 2 antigen testing ina community setting, Wisconsin, November2020–Decem- ber 2020. Clin Infect Dis. 2021 Jul

  15. 15;73(Suppl1):S54–7. https://doi.org/10.1093/cid/ciab30915. Mboma O, Rieke E, Ahmad-Nejad P, Wirth S,Aydin M. Diagnostic performance of SARS-CoV-2rapid antigen test in a large, German cohort. Children[Internet]. 2021 [cited 2021 Nov 29];8:682.https://doi.org/10.3390/children8080682

  16. World Health Organization. Geneva: WorldHealth Organization; c2022. Publications. Overview.Antigen-detection in the diagnosis of SARSCoV-2 infection: Interim guidance; 2021 Oct 6. 20p. Available at: https://www.who.int/publications/i/item/antigen-detection-in-the-diagnosis-of-sars-cov-2infection-using-rapid-immunoassays

  17. Pelegrino Martínez de la Cotera JL, RodríguezLay L, Guzmán Tirado MG. Evaluación de laprueba inmunocromatográfica Sars-Cov-2 Rapidantigen test para detectar antígenos de Sars-Cov-2. Rev Cubana Med Trop [Internet]. 2021Aug 1 [cited 2021 Nov 29];73(2):e682. Availableat: http://www.revmedtropical.sld.cu/index.php/medtropical/article/view/682/523. Spanish.

  18. Thell R, Kallab V, Weinhappel W, Mueckstein W,Heschl L, Heschl M, et al. Evaluation of anovel, rapid antigen detection test for the diagnosisof SARS-CoV-2. PLoS One. 2021 Nov29;16(11):e0259527. https://doi.org/10.1371/journal.pone.0259527

  19. Mboumba Bouassa RS, Veyer D, Péré H, BélecL. Analytical performances of the point-of-careSIENNA™COVID-19 antigen rapid test for thedetection of SARS-CoV-2 nucleocapsid proteinin nasopharyngeal swabs: a prospectiveevaluation during the COVID-19 second wave inFrance. Int J Infect Dis. 2021 May 1;106:8–12.https://doi.org/10.1016/j.ijid.2021.03.051 PMID:33746093.

  20. Foundation for Innovative New Diagnostics. FINDevaluation of SD Biosensor, Inc. STANDARD™FCOVID-19 Ag FIA. External Report Version 2.1,10 December 2020 [Internet]. Geneva: Foundationfor Innovative New Diagnostics; 2020 Dec[cited 2021 Dec 6]. 5 p. Available at: https://www.finddx.org/wp-content/uploads/2020/12/STANDARD_F_Ag-Public-Report_20201210-v2-1.pdf

  21. Liotti FM, Menchinelli G, Lalle E, Palucci I, MarchettiS, Colavita F, et al. Performance of a noveldiagnostic assay for rapid SARS-CoV-2 antigendetection in nasopharynx samples. Clin MicrobiolInfect. 2020 Mar 1;27:487–8. https://doi.org/10.1016/j.cmi.2020.09.030 PMID: 32979567.

  22. Weitzel T, Legarraga P, Iruretagoyena M, PizarroG, Vollrath V, Araos R, et al. Comparative evaluationof four rapid SARS-CoV-2 antigen detectiontests using universal transport medium.Travel Med Infect Dis. 2020;39:101942. https://doi.org/10.1016/j.tmaid.2020.101942 PMID: 33278609.

  23. Gupta A, Khurana S, Das R, Srigyan D, SinghA, Mittal A, et al. Rapid chromatographic immunoassaybasedevaluation of COVID-19: a crosssectional,diagnostic test accuracy study & itsimplications for COVID-19 management in India.Indian J Med Res. 2020;153(1):126. https://doi.org/10.4103/ijmr.IJMR_3305_20.

  24. Ministry of Health (AR). Consenso sobre el usode pruebas diagnósticas para SARS-CoV-2[Internet]. Caba (AR): Sociedad Argentina deMedicina; 2021 May [cited 2021 Dec 2]. 42 p.Available at: https://www.samsociedad.com.ar/noticia/consenso-sobre-el-uso-de-pruebas-diagn-sticas-para-sars-cov-2-/1124. Spanish.

  25. World Health Organization [Internet]. Geneva:World Health Organization; c2022. Todo IRIS.Esta Colección. Realización de pruebas dediagnóstico de la COVID-19 en el contexto delos viajes internacionales. Nota científica, 16 dediciembre 2020; 2020 Dec 16 [cited 2021 Dec2]. 5 p. Available at: https://apps.who.int/iris/handle/10665/339883. Spanish.

  26. Acta Sanitaria [Internet]. Madrid: Acta Sanitaria;c2022. Tecnología e Investigación. La OMSadvierte de la disminución del valor predictivopositivo de las PCR para Covid-19; 2021 Jan22 [cited 2021 Jun 4]; [about 2 p.]. Available at:https://www.actasanitaria.com/oms-predictivo-pcr/. Spanish.

  27. European Centre for Disease Prevention andControl. Technical Report. Options for the use ofrapid antigen tests for COVID-19 in the EU/EEAand the UK [Internet]. Stockholm County (SE):European Centre for Disease Prevention andControl; 2020 Nov 19 [cited 2021 Nov 29]. 22 p.Available at: https://www.ecdc.europa.eu/sites/default/files/documents/Options-use-of-rapid-antigen-tests-for-COVID19-19-11-2020.pdf

  28. Berger A, Ngo Nsoga MT, Pérez Rodríguez FJ,Diagnostic accuracy of two commercial SARSCoV-2 Antigen-detecting rapid tests at the pointof care in community-based testing centers.PloS One. 2021 Mar 31;16(3):e0248921. https://doi.org/10.1371/journal.pone.0248921. PMID:33788882; PMCID: PMC8011749.

  29. Takeuchi Y, Akashi Y, Kato D, Kuwahara M, MuramatsuS, Ueda A, et al. The evaluation of a newlydeveloped antigen test (QuickNaviTM-COVID19Ag) for SARS-CoV-2: a prospective observationalstudy in Japan. J Infect Chemother. 2021Jun 1; 27(6):890–4. https://doi.org/10.1016/j.jiac.2021.02.029

  30. Gili A, Paggi R, Russo C, Cenci E, Pietrella D,Graziani D, et al. Evaluation of Lumipulse GSARS-CoV-2 antigen assay automated test fordetecting SARS-CoV-2 nucleocapsid protein(NP) innasopharyngeal swabs for community andpopulation screening. 2021. Int J Infect Dis. 2021Apr 1;105:391–6. https://doi.org/10.1016/j.ijid.2021.02.098

  31. Thirion-Romero I, Guerrero-Zúñiga S, Arias-Mendoza A, Cornejo Juárez DP, Meza-MenesesP, Torres-Erazo DS, et al. Evaluation of Panbiorapid antigen test for SARS-CoV-2 in symptomaticpatients and their contacts: a multicenter study.Int J Infect Dis. 2021 Dec 1;113:218–24. https://doi.org/10.1016/j.ijid.2021.10.027




2020     |     www.medigraphic.com